APC p.Val1822Asp
Variant summary
The NM_000038.6(APC):c.5465T>A (p.Val1822Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.781 (AC=1,257,991) in the gnomAD database across 1,611,172 control chromosomes, including 493,662 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.952. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V1822D: Benign (ClinVar VariationId 3304266, 1 star); p.V1822D: Uncertain_significance (ClinVar VariationId 3343773, 1 star); p.V1822E: Uncertain_significance (ClinVar VariationId 963607, 1 star); p.V1822G: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 231079); p.V1822I: Uncertain_significance (ClinVar VariationId 3411135, 1 star); p.V1822= (synonymous): Likely_benign (ClinVar VariationId 2452708, 1 star); p.V1822= (synonymous): Benign/Likely_benign (ClinVar VariationId 3254437, 2 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000038.6 missense
Scores
Clinical Significance
Conservation
Publications
- classic or attenuated familial adenomatous polyposisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- desmoid tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- familial adenomatous polyposis 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- gastric adenocarcinoma and proximal polyposis of the stomachInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Benign. The variant received -17 points.
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000038.6. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APC | MANE Select | c.5465T>A | p.Val1822Asp | missense | Exon 16 of 16 | NP_000029.2 | |||
| APC | c.5549T>A | p.Val1850Asp | missense | Exon 16 of 16 | NP_001394375.1 | ||||
| APC | c.5519T>A | p.Val1840Asp | missense | Exon 17 of 17 | NP_001341825.1 | R4GMU6 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APC | TSL:5 MANE Select | c.5465T>A | p.Val1822Asp | missense | Exon 16 of 16 | ENSP00000257430.4 | P25054-1 | ||
| APC | TSL:1 | c.5465T>A | p.Val1822Asp | missense | Exon 17 of 17 | ENSP00000427089.2 | P25054-1 | ||
| APC | TSL:1 | n.*4787T>A | 3_prime_UTR | Exon 17 of 17 | ENSP00000424265.1 | E7EMH9 |
Frequencies
GnomAD3 genomes AF: 0.820 AC: 124670AN: 152042Hom.: 51821 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.795 AC: 199083AN: 250474 AF XY: 0.789 show subpopulations
GnomAD4 exome AF: 0.777 AC: 1133202AN: 1459012Hom.: 441782 Cov.: 53 AF XY: 0.776 AC XY: 563110AN XY: 725998 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.820 AC: 124789AN: 152160Hom.: 51880 Cov.: 31 AF XY: 0.816 AC XY: 60692AN XY: 74374 show subpopulations
Age Distribution
Local populations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.